BiotechTube
Home/Tempus AI/Kate Sasser, PhD
KS

Kate Sasser, PhD

Chief Scientific Officer

Tempus AI

Therapeutic Areas

OncologyCardiologyNeurologyPsychiatryInfectious Disease

Tempus AI Pipeline

DrugIndicationPhase
TEM-1Oncology (Undisclosed)Discovery/Preclinical
TEM-2Oncology (Undisclosed)Discovery/Preclinical
TEM-3Oncology (Undisclosed)Discovery/Preclinical
TEM-4Oncology (Undisclosed)Discovery/Preclinical
TEM-5Oncology (Undisclosed)Discovery/Preclinical
TEM-6Oncology (Undisclosed)Discovery/Preclinical
TEM-7Oncology (Undisclosed)Discovery/Preclinical

Leadership Team at Tempus AI

EL
Eric Lefkofsky
Founder & CEO
CA
Christina Antoniou
Senior Vice President, Head of Corporate Development
TB
Terron Bruner
Chief Commercial Officer
EC
Ezra Cohen, MD
Chief Medical Officer of Oncology
SC
Shane Colley
Chief Technology Officer
RE
Robyn Eckerling
Chief Privacy Officer
LE
Laura Elster
Senior Vice President, Healthcare Innovation & Transformation
GF
Greg Fisbeck
Chief Information Security Officer
RF
Ryan Fukushima
Chief Operating Officer
SK
Stacey Kraft
Chief People Officer
View full Tempus AI profile